Medical Care
Global Neglected Tropical Disease (NTD) Treatment Market Research Report 2025
- Sep 18, 25
- ID: 507030
- Pages: 74
- Figures: 78
- Views: 19
This report aims to provide a comprehensive presentation of the global market for Neglected Tropical Disease (NTD) Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Neglected Tropical Disease (NTD) Treatment.
The Neglected Tropical Disease (NTD) Treatment market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Neglected Tropical Disease (NTD) Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Neglected Tropical Disease (NTD) Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
F. Hoffmann-La Roche
Bayer
GlaxoSmithKline
Novartis
Pfizer
Eisai
Sanofi
Astellas Pharma
Takeda Pharmaceutical Company
Gilead Sciences
Segment by Type
Drugs
Vaccines
Segment by Application
Hospitals and Clinics
Diagnostic Centers
Academic and Research Organizations
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Neglected Tropical Disease (NTD) Treatment company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The Neglected Tropical Disease (NTD) Treatment market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Neglected Tropical Disease (NTD) Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Neglected Tropical Disease (NTD) Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
F. Hoffmann-La Roche
Bayer
GlaxoSmithKline
Novartis
Pfizer
Eisai
Sanofi
Astellas Pharma
Takeda Pharmaceutical Company
Gilead Sciences
Segment by Type
Drugs
Vaccines
Segment by Application
Hospitals and Clinics
Diagnostic Centers
Academic and Research Organizations
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Neglected Tropical Disease (NTD) Treatment company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Neglected Tropical Disease (NTD) Treatment Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Drugs
1.2.3 Vaccines
1.3 Market by Application
1.3.1 Global Neglected Tropical Disease (NTD) Treatment Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospitals and Clinics
1.3.3 Diagnostic Centers
1.3.4 Academic and Research Organizations
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Neglected Tropical Disease (NTD) Treatment Market Perspective (2020-2031)
2.2 Global Neglected Tropical Disease (NTD) Treatment Growth Trends by Region
2.2.1 Global Neglected Tropical Disease (NTD) Treatment Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Neglected Tropical Disease (NTD) Treatment Historic Market Size by Region (2020-2025)
2.2.3 Neglected Tropical Disease (NTD) Treatment Forecasted Market Size by Region (2026-2031)
2.3 Neglected Tropical Disease (NTD) Treatment Market Dynamics
2.3.1 Neglected Tropical Disease (NTD) Treatment Industry Trends
2.3.2 Neglected Tropical Disease (NTD) Treatment Market Drivers
2.3.3 Neglected Tropical Disease (NTD) Treatment Market Challenges
2.3.4 Neglected Tropical Disease (NTD) Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Neglected Tropical Disease (NTD) Treatment Players by Revenue
3.1.1 Global Top Neglected Tropical Disease (NTD) Treatment Players by Revenue (2020-2025)
3.1.2 Global Neglected Tropical Disease (NTD) Treatment Revenue Market Share by Players (2020-2025)
3.2 Global Neglected Tropical Disease (NTD) Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Neglected Tropical Disease (NTD) Treatment Revenue
3.4 Global Neglected Tropical Disease (NTD) Treatment Market Concentration Ratio
3.4.1 Global Neglected Tropical Disease (NTD) Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Neglected Tropical Disease (NTD) Treatment Revenue in 2024
3.5 Global Key Players of Neglected Tropical Disease (NTD) Treatment Head office and Area Served
3.6 Global Key Players of Neglected Tropical Disease (NTD) Treatment, Product and Application
3.7 Global Key Players of Neglected Tropical Disease (NTD) Treatment, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Neglected Tropical Disease (NTD) Treatment Breakdown Data by Type
4.1 Global Neglected Tropical Disease (NTD) Treatment Historic Market Size by Type (2020-2025)
4.2 Global Neglected Tropical Disease (NTD) Treatment Forecasted Market Size by Type (2026-2031)
5 Neglected Tropical Disease (NTD) Treatment Breakdown Data by Application
5.1 Global Neglected Tropical Disease (NTD) Treatment Historic Market Size by Application (2020-2025)
5.2 Global Neglected Tropical Disease (NTD) Treatment Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Neglected Tropical Disease (NTD) Treatment Market Size (2020-2031)
6.2 North America Neglected Tropical Disease (NTD) Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Neglected Tropical Disease (NTD) Treatment Market Size by Country (2020-2025)
6.4 North America Neglected Tropical Disease (NTD) Treatment Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Neglected Tropical Disease (NTD) Treatment Market Size (2020-2031)
7.2 Europe Neglected Tropical Disease (NTD) Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Neglected Tropical Disease (NTD) Treatment Market Size by Country (2020-2025)
7.4 Europe Neglected Tropical Disease (NTD) Treatment Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Neglected Tropical Disease (NTD) Treatment Market Size (2020-2031)
8.2 Asia-Pacific Neglected Tropical Disease (NTD) Treatment Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Neglected Tropical Disease (NTD) Treatment Market Size by Region (2020-2025)
8.4 Asia-Pacific Neglected Tropical Disease (NTD) Treatment Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Neglected Tropical Disease (NTD) Treatment Market Size (2020-2031)
9.2 Latin America Neglected Tropical Disease (NTD) Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Neglected Tropical Disease (NTD) Treatment Market Size by Country (2020-2025)
9.4 Latin America Neglected Tropical Disease (NTD) Treatment Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Neglected Tropical Disease (NTD) Treatment Market Size (2020-2031)
10.2 Middle East & Africa Neglected Tropical Disease (NTD) Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Neglected Tropical Disease (NTD) Treatment Market Size by Country (2020-2025)
10.4 Middle East & Africa Neglected Tropical Disease (NTD) Treatment Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 F. Hoffmann-La Roche
11.1.1 F. Hoffmann-La Roche Company Details
11.1.2 F. Hoffmann-La Roche Business Overview
11.1.3 F. Hoffmann-La Roche Neglected Tropical Disease (NTD) Treatment Introduction
11.1.4 F. Hoffmann-La Roche Revenue in Neglected Tropical Disease (NTD) Treatment Business (2020-2025)
11.1.5 F. Hoffmann-La Roche Recent Development
11.2 Bayer
11.2.1 Bayer Company Details
11.2.2 Bayer Business Overview
11.2.3 Bayer Neglected Tropical Disease (NTD) Treatment Introduction
11.2.4 Bayer Revenue in Neglected Tropical Disease (NTD) Treatment Business (2020-2025)
11.2.5 Bayer Recent Development
11.3 GlaxoSmithKline
11.3.1 GlaxoSmithKline Company Details
11.3.2 GlaxoSmithKline Business Overview
11.3.3 GlaxoSmithKline Neglected Tropical Disease (NTD) Treatment Introduction
11.3.4 GlaxoSmithKline Revenue in Neglected Tropical Disease (NTD) Treatment Business (2020-2025)
11.3.5 GlaxoSmithKline Recent Development
11.4 Novartis
11.4.1 Novartis Company Details
11.4.2 Novartis Business Overview
11.4.3 Novartis Neglected Tropical Disease (NTD) Treatment Introduction
11.4.4 Novartis Revenue in Neglected Tropical Disease (NTD) Treatment Business (2020-2025)
11.4.5 Novartis Recent Development
11.5 Pfizer
11.5.1 Pfizer Company Details
11.5.2 Pfizer Business Overview
11.5.3 Pfizer Neglected Tropical Disease (NTD) Treatment Introduction
11.5.4 Pfizer Revenue in Neglected Tropical Disease (NTD) Treatment Business (2020-2025)
11.5.5 Pfizer Recent Development
11.6 Eisai
11.6.1 Eisai Company Details
11.6.2 Eisai Business Overview
11.6.3 Eisai Neglected Tropical Disease (NTD) Treatment Introduction
11.6.4 Eisai Revenue in Neglected Tropical Disease (NTD) Treatment Business (2020-2025)
11.6.5 Eisai Recent Development
11.7 Sanofi
11.7.1 Sanofi Company Details
11.7.2 Sanofi Business Overview
11.7.3 Sanofi Neglected Tropical Disease (NTD) Treatment Introduction
11.7.4 Sanofi Revenue in Neglected Tropical Disease (NTD) Treatment Business (2020-2025)
11.7.5 Sanofi Recent Development
11.8 Astellas Pharma
11.8.1 Astellas Pharma Company Details
11.8.2 Astellas Pharma Business Overview
11.8.3 Astellas Pharma Neglected Tropical Disease (NTD) Treatment Introduction
11.8.4 Astellas Pharma Revenue in Neglected Tropical Disease (NTD) Treatment Business (2020-2025)
11.8.5 Astellas Pharma Recent Development
11.9 Takeda Pharmaceutical Company
11.9.1 Takeda Pharmaceutical Company Company Details
11.9.2 Takeda Pharmaceutical Company Business Overview
11.9.3 Takeda Pharmaceutical Company Neglected Tropical Disease (NTD) Treatment Introduction
11.9.4 Takeda Pharmaceutical Company Revenue in Neglected Tropical Disease (NTD) Treatment Business (2020-2025)
11.9.5 Takeda Pharmaceutical Company Recent Development
11.10 Gilead Sciences
11.10.1 Gilead Sciences Company Details
11.10.2 Gilead Sciences Business Overview
11.10.3 Gilead Sciences Neglected Tropical Disease (NTD) Treatment Introduction
11.10.4 Gilead Sciences Revenue in Neglected Tropical Disease (NTD) Treatment Business (2020-2025)
11.10.5 Gilead Sciences Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Neglected Tropical Disease (NTD) Treatment Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Drugs
1.2.3 Vaccines
1.3 Market by Application
1.3.1 Global Neglected Tropical Disease (NTD) Treatment Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospitals and Clinics
1.3.3 Diagnostic Centers
1.3.4 Academic and Research Organizations
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Neglected Tropical Disease (NTD) Treatment Market Perspective (2020-2031)
2.2 Global Neglected Tropical Disease (NTD) Treatment Growth Trends by Region
2.2.1 Global Neglected Tropical Disease (NTD) Treatment Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Neglected Tropical Disease (NTD) Treatment Historic Market Size by Region (2020-2025)
2.2.3 Neglected Tropical Disease (NTD) Treatment Forecasted Market Size by Region (2026-2031)
2.3 Neglected Tropical Disease (NTD) Treatment Market Dynamics
2.3.1 Neglected Tropical Disease (NTD) Treatment Industry Trends
2.3.2 Neglected Tropical Disease (NTD) Treatment Market Drivers
2.3.3 Neglected Tropical Disease (NTD) Treatment Market Challenges
2.3.4 Neglected Tropical Disease (NTD) Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Neglected Tropical Disease (NTD) Treatment Players by Revenue
3.1.1 Global Top Neglected Tropical Disease (NTD) Treatment Players by Revenue (2020-2025)
3.1.2 Global Neglected Tropical Disease (NTD) Treatment Revenue Market Share by Players (2020-2025)
3.2 Global Neglected Tropical Disease (NTD) Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Neglected Tropical Disease (NTD) Treatment Revenue
3.4 Global Neglected Tropical Disease (NTD) Treatment Market Concentration Ratio
3.4.1 Global Neglected Tropical Disease (NTD) Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Neglected Tropical Disease (NTD) Treatment Revenue in 2024
3.5 Global Key Players of Neglected Tropical Disease (NTD) Treatment Head office and Area Served
3.6 Global Key Players of Neglected Tropical Disease (NTD) Treatment, Product and Application
3.7 Global Key Players of Neglected Tropical Disease (NTD) Treatment, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Neglected Tropical Disease (NTD) Treatment Breakdown Data by Type
4.1 Global Neglected Tropical Disease (NTD) Treatment Historic Market Size by Type (2020-2025)
4.2 Global Neglected Tropical Disease (NTD) Treatment Forecasted Market Size by Type (2026-2031)
5 Neglected Tropical Disease (NTD) Treatment Breakdown Data by Application
5.1 Global Neglected Tropical Disease (NTD) Treatment Historic Market Size by Application (2020-2025)
5.2 Global Neglected Tropical Disease (NTD) Treatment Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Neglected Tropical Disease (NTD) Treatment Market Size (2020-2031)
6.2 North America Neglected Tropical Disease (NTD) Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Neglected Tropical Disease (NTD) Treatment Market Size by Country (2020-2025)
6.4 North America Neglected Tropical Disease (NTD) Treatment Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Neglected Tropical Disease (NTD) Treatment Market Size (2020-2031)
7.2 Europe Neglected Tropical Disease (NTD) Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Neglected Tropical Disease (NTD) Treatment Market Size by Country (2020-2025)
7.4 Europe Neglected Tropical Disease (NTD) Treatment Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Neglected Tropical Disease (NTD) Treatment Market Size (2020-2031)
8.2 Asia-Pacific Neglected Tropical Disease (NTD) Treatment Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Neglected Tropical Disease (NTD) Treatment Market Size by Region (2020-2025)
8.4 Asia-Pacific Neglected Tropical Disease (NTD) Treatment Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Neglected Tropical Disease (NTD) Treatment Market Size (2020-2031)
9.2 Latin America Neglected Tropical Disease (NTD) Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Neglected Tropical Disease (NTD) Treatment Market Size by Country (2020-2025)
9.4 Latin America Neglected Tropical Disease (NTD) Treatment Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Neglected Tropical Disease (NTD) Treatment Market Size (2020-2031)
10.2 Middle East & Africa Neglected Tropical Disease (NTD) Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Neglected Tropical Disease (NTD) Treatment Market Size by Country (2020-2025)
10.4 Middle East & Africa Neglected Tropical Disease (NTD) Treatment Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 F. Hoffmann-La Roche
11.1.1 F. Hoffmann-La Roche Company Details
11.1.2 F. Hoffmann-La Roche Business Overview
11.1.3 F. Hoffmann-La Roche Neglected Tropical Disease (NTD) Treatment Introduction
11.1.4 F. Hoffmann-La Roche Revenue in Neglected Tropical Disease (NTD) Treatment Business (2020-2025)
11.1.5 F. Hoffmann-La Roche Recent Development
11.2 Bayer
11.2.1 Bayer Company Details
11.2.2 Bayer Business Overview
11.2.3 Bayer Neglected Tropical Disease (NTD) Treatment Introduction
11.2.4 Bayer Revenue in Neglected Tropical Disease (NTD) Treatment Business (2020-2025)
11.2.5 Bayer Recent Development
11.3 GlaxoSmithKline
11.3.1 GlaxoSmithKline Company Details
11.3.2 GlaxoSmithKline Business Overview
11.3.3 GlaxoSmithKline Neglected Tropical Disease (NTD) Treatment Introduction
11.3.4 GlaxoSmithKline Revenue in Neglected Tropical Disease (NTD) Treatment Business (2020-2025)
11.3.5 GlaxoSmithKline Recent Development
11.4 Novartis
11.4.1 Novartis Company Details
11.4.2 Novartis Business Overview
11.4.3 Novartis Neglected Tropical Disease (NTD) Treatment Introduction
11.4.4 Novartis Revenue in Neglected Tropical Disease (NTD) Treatment Business (2020-2025)
11.4.5 Novartis Recent Development
11.5 Pfizer
11.5.1 Pfizer Company Details
11.5.2 Pfizer Business Overview
11.5.3 Pfizer Neglected Tropical Disease (NTD) Treatment Introduction
11.5.4 Pfizer Revenue in Neglected Tropical Disease (NTD) Treatment Business (2020-2025)
11.5.5 Pfizer Recent Development
11.6 Eisai
11.6.1 Eisai Company Details
11.6.2 Eisai Business Overview
11.6.3 Eisai Neglected Tropical Disease (NTD) Treatment Introduction
11.6.4 Eisai Revenue in Neglected Tropical Disease (NTD) Treatment Business (2020-2025)
11.6.5 Eisai Recent Development
11.7 Sanofi
11.7.1 Sanofi Company Details
11.7.2 Sanofi Business Overview
11.7.3 Sanofi Neglected Tropical Disease (NTD) Treatment Introduction
11.7.4 Sanofi Revenue in Neglected Tropical Disease (NTD) Treatment Business (2020-2025)
11.7.5 Sanofi Recent Development
11.8 Astellas Pharma
11.8.1 Astellas Pharma Company Details
11.8.2 Astellas Pharma Business Overview
11.8.3 Astellas Pharma Neglected Tropical Disease (NTD) Treatment Introduction
11.8.4 Astellas Pharma Revenue in Neglected Tropical Disease (NTD) Treatment Business (2020-2025)
11.8.5 Astellas Pharma Recent Development
11.9 Takeda Pharmaceutical Company
11.9.1 Takeda Pharmaceutical Company Company Details
11.9.2 Takeda Pharmaceutical Company Business Overview
11.9.3 Takeda Pharmaceutical Company Neglected Tropical Disease (NTD) Treatment Introduction
11.9.4 Takeda Pharmaceutical Company Revenue in Neglected Tropical Disease (NTD) Treatment Business (2020-2025)
11.9.5 Takeda Pharmaceutical Company Recent Development
11.10 Gilead Sciences
11.10.1 Gilead Sciences Company Details
11.10.2 Gilead Sciences Business Overview
11.10.3 Gilead Sciences Neglected Tropical Disease (NTD) Treatment Introduction
11.10.4 Gilead Sciences Revenue in Neglected Tropical Disease (NTD) Treatment Business (2020-2025)
11.10.5 Gilead Sciences Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Neglected Tropical Disease (NTD) Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Drugs
Table 3. Key Players of Vaccines
Table 4. Global Neglected Tropical Disease (NTD) Treatment Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Neglected Tropical Disease (NTD) Treatment Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Neglected Tropical Disease (NTD) Treatment Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Neglected Tropical Disease (NTD) Treatment Market Share by Region (2020-2025)
Table 8. Global Neglected Tropical Disease (NTD) Treatment Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Neglected Tropical Disease (NTD) Treatment Market Share by Region (2026-2031)
Table 10. Neglected Tropical Disease (NTD) Treatment Market Trends
Table 11. Neglected Tropical Disease (NTD) Treatment Market Drivers
Table 12. Neglected Tropical Disease (NTD) Treatment Market Challenges
Table 13. Neglected Tropical Disease (NTD) Treatment Market Restraints
Table 14. Global Neglected Tropical Disease (NTD) Treatment Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Neglected Tropical Disease (NTD) Treatment Market Share by Players (2020-2025)
Table 16. Global Top Neglected Tropical Disease (NTD) Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neglected Tropical Disease (NTD) Treatment as of 2024)
Table 17. Ranking of Global Top Neglected Tropical Disease (NTD) Treatment Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Neglected Tropical Disease (NTD) Treatment Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Neglected Tropical Disease (NTD) Treatment, Headquarters and Area Served
Table 20. Global Key Players of Neglected Tropical Disease (NTD) Treatment, Product and Application
Table 21. Global Key Players of Neglected Tropical Disease (NTD) Treatment, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Neglected Tropical Disease (NTD) Treatment Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Neglected Tropical Disease (NTD) Treatment Revenue Market Share by Type (2020-2025)
Table 25. Global Neglected Tropical Disease (NTD) Treatment Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Neglected Tropical Disease (NTD) Treatment Revenue Market Share by Type (2026-2031)
Table 27. Global Neglected Tropical Disease (NTD) Treatment Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Neglected Tropical Disease (NTD) Treatment Revenue Market Share by Application (2020-2025)
Table 29. Global Neglected Tropical Disease (NTD) Treatment Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Neglected Tropical Disease (NTD) Treatment Revenue Market Share by Application (2026-2031)
Table 31. North America Neglected Tropical Disease (NTD) Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Neglected Tropical Disease (NTD) Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Neglected Tropical Disease (NTD) Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Neglected Tropical Disease (NTD) Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Neglected Tropical Disease (NTD) Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Neglected Tropical Disease (NTD) Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Neglected Tropical Disease (NTD) Treatment Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Neglected Tropical Disease (NTD) Treatment Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Neglected Tropical Disease (NTD) Treatment Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Neglected Tropical Disease (NTD) Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Neglected Tropical Disease (NTD) Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Neglected Tropical Disease (NTD) Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Neglected Tropical Disease (NTD) Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Neglected Tropical Disease (NTD) Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Neglected Tropical Disease (NTD) Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 46. F. Hoffmann-La Roche Company Details
Table 47. F. Hoffmann-La Roche Business Overview
Table 48. F. Hoffmann-La Roche Neglected Tropical Disease (NTD) Treatment Product
Table 49. F. Hoffmann-La Roche Revenue in Neglected Tropical Disease (NTD) Treatment Business (2020-2025) & (US$ Million)
Table 50. F. Hoffmann-La Roche Recent Development
Table 51. Bayer Company Details
Table 52. Bayer Business Overview
Table 53. Bayer Neglected Tropical Disease (NTD) Treatment Product
Table 54. Bayer Revenue in Neglected Tropical Disease (NTD) Treatment Business (2020-2025) & (US$ Million)
Table 55. Bayer Recent Development
Table 56. GlaxoSmithKline Company Details
Table 57. GlaxoSmithKline Business Overview
Table 58. GlaxoSmithKline Neglected Tropical Disease (NTD) Treatment Product
Table 59. GlaxoSmithKline Revenue in Neglected Tropical Disease (NTD) Treatment Business (2020-2025) & (US$ Million)
Table 60. GlaxoSmithKline Recent Development
Table 61. Novartis Company Details
Table 62. Novartis Business Overview
Table 63. Novartis Neglected Tropical Disease (NTD) Treatment Product
Table 64. Novartis Revenue in Neglected Tropical Disease (NTD) Treatment Business (2020-2025) & (US$ Million)
Table 65. Novartis Recent Development
Table 66. Pfizer Company Details
Table 67. Pfizer Business Overview
Table 68. Pfizer Neglected Tropical Disease (NTD) Treatment Product
Table 69. Pfizer Revenue in Neglected Tropical Disease (NTD) Treatment Business (2020-2025) & (US$ Million)
Table 70. Pfizer Recent Development
Table 71. Eisai Company Details
Table 72. Eisai Business Overview
Table 73. Eisai Neglected Tropical Disease (NTD) Treatment Product
Table 74. Eisai Revenue in Neglected Tropical Disease (NTD) Treatment Business (2020-2025) & (US$ Million)
Table 75. Eisai Recent Development
Table 76. Sanofi Company Details
Table 77. Sanofi Business Overview
Table 78. Sanofi Neglected Tropical Disease (NTD) Treatment Product
Table 79. Sanofi Revenue in Neglected Tropical Disease (NTD) Treatment Business (2020-2025) & (US$ Million)
Table 80. Sanofi Recent Development
Table 81. Astellas Pharma Company Details
Table 82. Astellas Pharma Business Overview
Table 83. Astellas Pharma Neglected Tropical Disease (NTD) Treatment Product
Table 84. Astellas Pharma Revenue in Neglected Tropical Disease (NTD) Treatment Business (2020-2025) & (US$ Million)
Table 85. Astellas Pharma Recent Development
Table 86. Takeda Pharmaceutical Company Company Details
Table 87. Takeda Pharmaceutical Company Business Overview
Table 88. Takeda Pharmaceutical Company Neglected Tropical Disease (NTD) Treatment Product
Table 89. Takeda Pharmaceutical Company Revenue in Neglected Tropical Disease (NTD) Treatment Business (2020-2025) & (US$ Million)
Table 90. Takeda Pharmaceutical Company Recent Development
Table 91. Gilead Sciences Company Details
Table 92. Gilead Sciences Business Overview
Table 93. Gilead Sciences Neglected Tropical Disease (NTD) Treatment Product
Table 94. Gilead Sciences Revenue in Neglected Tropical Disease (NTD) Treatment Business (2020-2025) & (US$ Million)
Table 95. Gilead Sciences Recent Development
Table 96. Research Programs/Design for This Report
Table 97. Key Data Information from Secondary Sources
Table 98. Key Data Information from Primary Sources
Table 99. Authors List of This Report
List of Figures
Figure 1. Neglected Tropical Disease (NTD) Treatment Picture
Figure 2. Global Neglected Tropical Disease (NTD) Treatment Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Neglected Tropical Disease (NTD) Treatment Market Share by Type: 2024 VS 2031
Figure 4. Drugs Features
Figure 5. Vaccines Features
Figure 6. Global Neglected Tropical Disease (NTD) Treatment Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Neglected Tropical Disease (NTD) Treatment Market Share by Application: 2024 VS 2031
Figure 8. Hospitals and Clinics Case Studies
Figure 9. Diagnostic Centers Case Studies
Figure 10. Academic and Research Organizations Case Studies
Figure 11. Neglected Tropical Disease (NTD) Treatment Report Years Considered
Figure 12. Global Neglected Tropical Disease (NTD) Treatment Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 13. Global Neglected Tropical Disease (NTD) Treatment Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Neglected Tropical Disease (NTD) Treatment Market Share by Region: 2024 VS 2031
Figure 15. Global Neglected Tropical Disease (NTD) Treatment Market Share by Players in 2024
Figure 16. Global Top Neglected Tropical Disease (NTD) Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neglected Tropical Disease (NTD) Treatment as of 2024)
Figure 17. The Top 10 and 5 Players Market Share by Neglected Tropical Disease (NTD) Treatment Revenue in 2024
Figure 18. North America Neglected Tropical Disease (NTD) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 19. North America Neglected Tropical Disease (NTD) Treatment Market Share by Country (2020-2031)
Figure 20. United States Neglected Tropical Disease (NTD) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. Canada Neglected Tropical Disease (NTD) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Europe Neglected Tropical Disease (NTD) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Neglected Tropical Disease (NTD) Treatment Market Share by Country (2020-2031)
Figure 24. Germany Neglected Tropical Disease (NTD) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. France Neglected Tropical Disease (NTD) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. U.K. Neglected Tropical Disease (NTD) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Italy Neglected Tropical Disease (NTD) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Russia Neglected Tropical Disease (NTD) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Nordic Countries Neglected Tropical Disease (NTD) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Asia-Pacific Neglected Tropical Disease (NTD) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Neglected Tropical Disease (NTD) Treatment Market Share by Region (2020-2031)
Figure 32. China Neglected Tropical Disease (NTD) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Japan Neglected Tropical Disease (NTD) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. South Korea Neglected Tropical Disease (NTD) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Southeast Asia Neglected Tropical Disease (NTD) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. India Neglected Tropical Disease (NTD) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Australia Neglected Tropical Disease (NTD) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Latin America Neglected Tropical Disease (NTD) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Neglected Tropical Disease (NTD) Treatment Market Share by Country (2020-2031)
Figure 40. Mexico Neglected Tropical Disease (NTD) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Brazil Neglected Tropical Disease (NTD) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Middle East & Africa Neglected Tropical Disease (NTD) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Neglected Tropical Disease (NTD) Treatment Market Share by Country (2020-2031)
Figure 44. Turkey Neglected Tropical Disease (NTD) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Saudi Arabia Neglected Tropical Disease (NTD) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. UAE Neglected Tropical Disease (NTD) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. F. Hoffmann-La Roche Revenue Growth Rate in Neglected Tropical Disease (NTD) Treatment Business (2020-2025)
Figure 48. Bayer Revenue Growth Rate in Neglected Tropical Disease (NTD) Treatment Business (2020-2025)
Figure 49. GlaxoSmithKline Revenue Growth Rate in Neglected Tropical Disease (NTD) Treatment Business (2020-2025)
Figure 50. Novartis Revenue Growth Rate in Neglected Tropical Disease (NTD) Treatment Business (2020-2025)
Figure 51. Pfizer Revenue Growth Rate in Neglected Tropical Disease (NTD) Treatment Business (2020-2025)
Figure 52. Eisai Revenue Growth Rate in Neglected Tropical Disease (NTD) Treatment Business (2020-2025)
Figure 53. Sanofi Revenue Growth Rate in Neglected Tropical Disease (NTD) Treatment Business (2020-2025)
Figure 54. Astellas Pharma Revenue Growth Rate in Neglected Tropical Disease (NTD) Treatment Business (2020-2025)
Figure 55. Takeda Pharmaceutical Company Revenue Growth Rate in Neglected Tropical Disease (NTD) Treatment Business (2020-2025)
Figure 56. Gilead Sciences Revenue Growth Rate in Neglected Tropical Disease (NTD) Treatment Business (2020-2025)
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed
Table 1. Global Neglected Tropical Disease (NTD) Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Drugs
Table 3. Key Players of Vaccines
Table 4. Global Neglected Tropical Disease (NTD) Treatment Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Neglected Tropical Disease (NTD) Treatment Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Neglected Tropical Disease (NTD) Treatment Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Neglected Tropical Disease (NTD) Treatment Market Share by Region (2020-2025)
Table 8. Global Neglected Tropical Disease (NTD) Treatment Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Neglected Tropical Disease (NTD) Treatment Market Share by Region (2026-2031)
Table 10. Neglected Tropical Disease (NTD) Treatment Market Trends
Table 11. Neglected Tropical Disease (NTD) Treatment Market Drivers
Table 12. Neglected Tropical Disease (NTD) Treatment Market Challenges
Table 13. Neglected Tropical Disease (NTD) Treatment Market Restraints
Table 14. Global Neglected Tropical Disease (NTD) Treatment Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Neglected Tropical Disease (NTD) Treatment Market Share by Players (2020-2025)
Table 16. Global Top Neglected Tropical Disease (NTD) Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neglected Tropical Disease (NTD) Treatment as of 2024)
Table 17. Ranking of Global Top Neglected Tropical Disease (NTD) Treatment Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Neglected Tropical Disease (NTD) Treatment Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Neglected Tropical Disease (NTD) Treatment, Headquarters and Area Served
Table 20. Global Key Players of Neglected Tropical Disease (NTD) Treatment, Product and Application
Table 21. Global Key Players of Neglected Tropical Disease (NTD) Treatment, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Neglected Tropical Disease (NTD) Treatment Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Neglected Tropical Disease (NTD) Treatment Revenue Market Share by Type (2020-2025)
Table 25. Global Neglected Tropical Disease (NTD) Treatment Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Neglected Tropical Disease (NTD) Treatment Revenue Market Share by Type (2026-2031)
Table 27. Global Neglected Tropical Disease (NTD) Treatment Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Neglected Tropical Disease (NTD) Treatment Revenue Market Share by Application (2020-2025)
Table 29. Global Neglected Tropical Disease (NTD) Treatment Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Neglected Tropical Disease (NTD) Treatment Revenue Market Share by Application (2026-2031)
Table 31. North America Neglected Tropical Disease (NTD) Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Neglected Tropical Disease (NTD) Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Neglected Tropical Disease (NTD) Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Neglected Tropical Disease (NTD) Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Neglected Tropical Disease (NTD) Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Neglected Tropical Disease (NTD) Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Neglected Tropical Disease (NTD) Treatment Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Neglected Tropical Disease (NTD) Treatment Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Neglected Tropical Disease (NTD) Treatment Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Neglected Tropical Disease (NTD) Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Neglected Tropical Disease (NTD) Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Neglected Tropical Disease (NTD) Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Neglected Tropical Disease (NTD) Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Neglected Tropical Disease (NTD) Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Neglected Tropical Disease (NTD) Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 46. F. Hoffmann-La Roche Company Details
Table 47. F. Hoffmann-La Roche Business Overview
Table 48. F. Hoffmann-La Roche Neglected Tropical Disease (NTD) Treatment Product
Table 49. F. Hoffmann-La Roche Revenue in Neglected Tropical Disease (NTD) Treatment Business (2020-2025) & (US$ Million)
Table 50. F. Hoffmann-La Roche Recent Development
Table 51. Bayer Company Details
Table 52. Bayer Business Overview
Table 53. Bayer Neglected Tropical Disease (NTD) Treatment Product
Table 54. Bayer Revenue in Neglected Tropical Disease (NTD) Treatment Business (2020-2025) & (US$ Million)
Table 55. Bayer Recent Development
Table 56. GlaxoSmithKline Company Details
Table 57. GlaxoSmithKline Business Overview
Table 58. GlaxoSmithKline Neglected Tropical Disease (NTD) Treatment Product
Table 59. GlaxoSmithKline Revenue in Neglected Tropical Disease (NTD) Treatment Business (2020-2025) & (US$ Million)
Table 60. GlaxoSmithKline Recent Development
Table 61. Novartis Company Details
Table 62. Novartis Business Overview
Table 63. Novartis Neglected Tropical Disease (NTD) Treatment Product
Table 64. Novartis Revenue in Neglected Tropical Disease (NTD) Treatment Business (2020-2025) & (US$ Million)
Table 65. Novartis Recent Development
Table 66. Pfizer Company Details
Table 67. Pfizer Business Overview
Table 68. Pfizer Neglected Tropical Disease (NTD) Treatment Product
Table 69. Pfizer Revenue in Neglected Tropical Disease (NTD) Treatment Business (2020-2025) & (US$ Million)
Table 70. Pfizer Recent Development
Table 71. Eisai Company Details
Table 72. Eisai Business Overview
Table 73. Eisai Neglected Tropical Disease (NTD) Treatment Product
Table 74. Eisai Revenue in Neglected Tropical Disease (NTD) Treatment Business (2020-2025) & (US$ Million)
Table 75. Eisai Recent Development
Table 76. Sanofi Company Details
Table 77. Sanofi Business Overview
Table 78. Sanofi Neglected Tropical Disease (NTD) Treatment Product
Table 79. Sanofi Revenue in Neglected Tropical Disease (NTD) Treatment Business (2020-2025) & (US$ Million)
Table 80. Sanofi Recent Development
Table 81. Astellas Pharma Company Details
Table 82. Astellas Pharma Business Overview
Table 83. Astellas Pharma Neglected Tropical Disease (NTD) Treatment Product
Table 84. Astellas Pharma Revenue in Neglected Tropical Disease (NTD) Treatment Business (2020-2025) & (US$ Million)
Table 85. Astellas Pharma Recent Development
Table 86. Takeda Pharmaceutical Company Company Details
Table 87. Takeda Pharmaceutical Company Business Overview
Table 88. Takeda Pharmaceutical Company Neglected Tropical Disease (NTD) Treatment Product
Table 89. Takeda Pharmaceutical Company Revenue in Neglected Tropical Disease (NTD) Treatment Business (2020-2025) & (US$ Million)
Table 90. Takeda Pharmaceutical Company Recent Development
Table 91. Gilead Sciences Company Details
Table 92. Gilead Sciences Business Overview
Table 93. Gilead Sciences Neglected Tropical Disease (NTD) Treatment Product
Table 94. Gilead Sciences Revenue in Neglected Tropical Disease (NTD) Treatment Business (2020-2025) & (US$ Million)
Table 95. Gilead Sciences Recent Development
Table 96. Research Programs/Design for This Report
Table 97. Key Data Information from Secondary Sources
Table 98. Key Data Information from Primary Sources
Table 99. Authors List of This Report
List of Figures
Figure 1. Neglected Tropical Disease (NTD) Treatment Picture
Figure 2. Global Neglected Tropical Disease (NTD) Treatment Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Neglected Tropical Disease (NTD) Treatment Market Share by Type: 2024 VS 2031
Figure 4. Drugs Features
Figure 5. Vaccines Features
Figure 6. Global Neglected Tropical Disease (NTD) Treatment Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Neglected Tropical Disease (NTD) Treatment Market Share by Application: 2024 VS 2031
Figure 8. Hospitals and Clinics Case Studies
Figure 9. Diagnostic Centers Case Studies
Figure 10. Academic and Research Organizations Case Studies
Figure 11. Neglected Tropical Disease (NTD) Treatment Report Years Considered
Figure 12. Global Neglected Tropical Disease (NTD) Treatment Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 13. Global Neglected Tropical Disease (NTD) Treatment Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Neglected Tropical Disease (NTD) Treatment Market Share by Region: 2024 VS 2031
Figure 15. Global Neglected Tropical Disease (NTD) Treatment Market Share by Players in 2024
Figure 16. Global Top Neglected Tropical Disease (NTD) Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neglected Tropical Disease (NTD) Treatment as of 2024)
Figure 17. The Top 10 and 5 Players Market Share by Neglected Tropical Disease (NTD) Treatment Revenue in 2024
Figure 18. North America Neglected Tropical Disease (NTD) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 19. North America Neglected Tropical Disease (NTD) Treatment Market Share by Country (2020-2031)
Figure 20. United States Neglected Tropical Disease (NTD) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. Canada Neglected Tropical Disease (NTD) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Europe Neglected Tropical Disease (NTD) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Neglected Tropical Disease (NTD) Treatment Market Share by Country (2020-2031)
Figure 24. Germany Neglected Tropical Disease (NTD) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. France Neglected Tropical Disease (NTD) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. U.K. Neglected Tropical Disease (NTD) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Italy Neglected Tropical Disease (NTD) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Russia Neglected Tropical Disease (NTD) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Nordic Countries Neglected Tropical Disease (NTD) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Asia-Pacific Neglected Tropical Disease (NTD) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Neglected Tropical Disease (NTD) Treatment Market Share by Region (2020-2031)
Figure 32. China Neglected Tropical Disease (NTD) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Japan Neglected Tropical Disease (NTD) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. South Korea Neglected Tropical Disease (NTD) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Southeast Asia Neglected Tropical Disease (NTD) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. India Neglected Tropical Disease (NTD) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Australia Neglected Tropical Disease (NTD) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Latin America Neglected Tropical Disease (NTD) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Neglected Tropical Disease (NTD) Treatment Market Share by Country (2020-2031)
Figure 40. Mexico Neglected Tropical Disease (NTD) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Brazil Neglected Tropical Disease (NTD) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Middle East & Africa Neglected Tropical Disease (NTD) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Neglected Tropical Disease (NTD) Treatment Market Share by Country (2020-2031)
Figure 44. Turkey Neglected Tropical Disease (NTD) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Saudi Arabia Neglected Tropical Disease (NTD) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. UAE Neglected Tropical Disease (NTD) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. F. Hoffmann-La Roche Revenue Growth Rate in Neglected Tropical Disease (NTD) Treatment Business (2020-2025)
Figure 48. Bayer Revenue Growth Rate in Neglected Tropical Disease (NTD) Treatment Business (2020-2025)
Figure 49. GlaxoSmithKline Revenue Growth Rate in Neglected Tropical Disease (NTD) Treatment Business (2020-2025)
Figure 50. Novartis Revenue Growth Rate in Neglected Tropical Disease (NTD) Treatment Business (2020-2025)
Figure 51. Pfizer Revenue Growth Rate in Neglected Tropical Disease (NTD) Treatment Business (2020-2025)
Figure 52. Eisai Revenue Growth Rate in Neglected Tropical Disease (NTD) Treatment Business (2020-2025)
Figure 53. Sanofi Revenue Growth Rate in Neglected Tropical Disease (NTD) Treatment Business (2020-2025)
Figure 54. Astellas Pharma Revenue Growth Rate in Neglected Tropical Disease (NTD) Treatment Business (2020-2025)
Figure 55. Takeda Pharmaceutical Company Revenue Growth Rate in Neglected Tropical Disease (NTD) Treatment Business (2020-2025)
Figure 56. Gilead Sciences Revenue Growth Rate in Neglected Tropical Disease (NTD) Treatment Business (2020-2025)
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Potassium Bromide Windows Market Research Report 2025
Dec 14, 25
Global Bio-based 1,10-Decanediol Diacrylate Market Research Report 2025
Dec 14, 25
Global Bio-based 1,5-Pentanediol Diacrylate(PDDA) Market Research Report 2025
Dec 14, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232